158 related articles for article (PubMed ID: 25603690)
21. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918
[TBL] [Abstract][Full Text] [Related]
22. Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.
Gilbar PJ; Pokharel K
J Oncol Pharm Pract; 2022 Mar; 28(2):466-470. PubMed ID: 34647821
[TBL] [Abstract][Full Text] [Related]
23. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
Bettoli V; Zauli S; Virgili A
J Dermatolog Treat; 2013 Jun; 24(3):235-7. PubMed ID: 23148804
[TBL] [Abstract][Full Text] [Related]
24. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
[No Abstract] [Full Text] [Related]
25. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.
Kraemer KH; DiGiovanna JJ; Moshell AN; Tarone RE; Peck GL
N Engl J Med; 1988 Jun; 318(25):1633-7. PubMed ID: 3287161
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature.
Schaffer JV; Orlow SJ
Dermatology; 2011; 223(2):97-103. PubMed ID: 22024645
[TBL] [Abstract][Full Text] [Related]
27. [Radiotherapy for cutaneous cancers with xeroderma pigmentosum].
Ben Salah H; Bahri M; Turki H; Abdelmoula M; Frikha M; Daoud J
Cancer Radiother; 2011 Aug; 15(5):400-3. PubMed ID: 21664850
[TBL] [Abstract][Full Text] [Related]
28. Electrochemotherapy for Non-melanoma Skin Cancer in a Child with Xeroderma Pigmentosum.
Baltás E; Kis E; Nagy N; Sohár N; Varga E; Széll M; Kemény L; Oláh J
Acta Derm Venereol; 2017 Aug; 97(8):962-964. PubMed ID: 28448100
[No Abstract] [Full Text] [Related]
29. Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.
Hennemann A; Collonge Rame MA; Puzenat E; Ged C; Harbon S; Aubin F; Nardin C
Acta Oncol; 2022 Sep; 61(9):1140-1142. PubMed ID: 35950634
[No Abstract] [Full Text] [Related]
30. [XERODERMA PIGMENTOSUM WITH BASAL CELL AND SPINOCELLULAR EPITHELIOMA AND MELANOMA].
GAUMOND E
Hautarzt; 1964 Aug; 15():448-50. PubMed ID: 14249295
[No Abstract] [Full Text] [Related]
31. [The present situation of neoadjuvant therapy for head and neck carcinoma].
Rikimaru F; Tomita K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
[TBL] [Abstract][Full Text] [Related]
32. Management of a young patient with xeroderma pigmentosum.
Leal-Khouri S; Hruza GJ; Hruza LL; Martin AG
Pediatr Dermatol; 1994 Mar; 11(1):72-5. PubMed ID: 8170856
[TBL] [Abstract][Full Text] [Related]
33. Xeroderma pigmentosum.
Zeligman I; Lutzner MA; Scott CI
Birth Defects Orig Artic Ser; 1971 Jun; 7(8):296-7. PubMed ID: 5173292
[No Abstract] [Full Text] [Related]
34. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
Grampurohit VU; Dinesh US; Rao R
J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
[TBL] [Abstract][Full Text] [Related]
35. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
[TBL] [Abstract][Full Text] [Related]
36. [Conjunctival epithelial carcinoma in a 9-year-old child with xeroderma pigmentosum. Case report].
Rouberol F; Burillon C; Kodjikian L; Simon P; Bouvier R; Denis P
J Fr Ophtalmol; 2001 Jun; 24(6):639-42. PubMed ID: 11460062
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
38. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.
Deinlein T; Lax SF; Schwarz T; Giuffrida R; Schmid-Zalaudek K; Zalaudek I
Eur J Cancer; 2017 Sep; 83():99-102. PubMed ID: 28734147
[No Abstract] [Full Text] [Related]
39. Xeroderma pigmentosum with bilateral ocular surface squamous neoplasia and review of the literature.
Kalamkar C; Radke N; Mukherjee A; Radke S
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27166000
[TBL] [Abstract][Full Text] [Related]
40. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
